The global mass spectrometry market size was estimated at USD 7.3 billion in 2025 and is projected to grow from USD 7.9 billion in 2026 to USD 13.2 billion by 2033, growing at a CAGR of 7.6% from 2026 to 2033. The market in North America dominated with a revenue share of 43.0% in 2025. Increasing R&D in the phar... Read More »
June 2026The global in-vitro diagnostics enzymes market size was valued at USD 1.9 billion in 2025 and is projected to grow from USD 2.1 billion in 2026 to USD 3.9 billion by 2033, at a CAGR of 9.4% from 2026 to 2033. North America held the largest share of 45.8% of the global market in 2025. Mar... Read More »
June 2026The global activated clotting time testing market size was valued at USD 1.2 billion in 2025 and is projected to grow from USD 1.3 billion in 2026 to USD 2.1 billion by 2033, at a CAGR of 7.6% from 2026 to 2033. North America dominated the global activated clotting time testing market wi... Read More »
June 2026The global urea breath testing market size was valued at USD 374.1 million in 2025 and is projected to grow from USD 380.6 million in 2026 to USD 515.9 million by 2033, at a CAGR of 4.4% from 2026 to 2033. The North America urea breath testing market held the largest share of 48.4% of th... Read More »
June 2026The global employer and workplace drug testing market size was valued at USD 6.3 billion in 2025 and is projected to grow from USD 6.6 billion in 2026 to USD 9.1 billion by 2033, at a CAGR of 4.7% from 2026 to 2033. The market in North America dominated with a revenue share of 49.16% in ... Read More »
June 2026The global syphilis testing market size was valued at USD 1.5 billion in 2025 and is projected to grow from USD 1.6 billion in 2026 to USD 2.3 billion by 2033, at a CAGR of 5.2% from 2026 to 2033. The North America syphilis testing market held the largest share of 36.32% of the global ma... Read More »
June 2026The Saudi Arabia zika virus testing market size was valued at USD 150.34 thousand in 2025 and is projected to grow from USD 156.01 thousand in 2026 to USD 200.25 thousand by 2033, at a CAGR of 3.63% from 2026 to 2033. Market growth is mainly due to rising international travel and pilgrim... Read More »
June 2026The Saudi Arabia dengue testing market was valued at USD 624.35 thousand in 2025 and is projected to grow from USD 654.00 thousand in 2026 to reach USD 889.83 thousand by 2033, growing at a CAGR of 4.50% from 2026 to 2033. The market is driven by the increasing prevalence of dengue infec... Read More »
June 2026The global drug screening market size was valued at USD 11.08 billion in 2025 and is projected to grow from USD 11.80 billion in 2026 to USD 19.09 billion by 2033, at a CAGR of 7.12% from 2026 to 2033. The North America drug screening industry accounted for the largest revenue share... Read More »
May 2026The global stool antigen testing market size was valued at USD 679.1 million in 2025 and is projected to grow from USD 762.2 million in 2026 to USD 1334.2 million by 2033, at a CAGR of 8.3% from 2026 to 2033. The North America stool antigen testing market held the largest share of 39.8% ... Read More »
May 2026The North America & Europe infectious disease molecular diagnostics market size was estimated at USD 6.09 billion in 2025 and is projected to reach USD 10.77 billion by 2033, growing at a CAGR of 7.44% from 2026 to 2033. The market is driven by the increasing burden of infectious dis... Read More »
May 2026The global immunoassay for neurological biomarkers market size was estimated at USD 1.08 billion in 2025 and is projected to reach USD 2.12 billion by 2033, growing at a CAGR of 8.91% from 2026 to 2033. Growth is supported by the rising prevalence of neurodegenerative diseases, increasin... Read More »
May 2026The U.S. CLIA endocrine testing market size was estimated at USD 14.1 billion in 2025 and is projected to reach USD 34.4 billion by 2033, growing at a CAGR of 11.9% from 2026 to 2033. Market growth is supported by the increasing prevalence of chronic and hormonal disorders and the need f... Read More »
May 2026The global allergy diagnostics market size was valued at USD 7.09 billion in 2025 and is projected to reach USD 16.37 billion by 2033, growing at a CAGR of 11.29% from 2026 to 2033. The growth is driven by the rising incidence of conditions such as allergic rhinitis, asthma, atopic derma... Read More »
May 2026The global companion diagnostics market size was valued at USD 9.6 billion in 2025 and is projected to grow from USD 10.3 billion in 2026 to USD 20.1 billion by 2033, at a CAGR of 10.1% from 2026 to 2033. North America dominated the market with a revenue share of 39.9% in 2025. Growth is... Read More »
May 2026The U.S. non-invasive cancer diagnostics market was estimated at USD 27.08 billion in 2025 and is projected to reach USD 47.52 billion in 2033, growing at a CAGR of 7.4% from 2026 to 2033. The growth is driven by the continuous advancements in diagnostic technologies, the rising prevalen... Read More »
May 2026The global blood group typing market was valued at USD 2.31 billion in 2025 and is projected to reach USD 5.59 billion by 2033, growing at a CAGR of 11.99% from 2026 to 2033. Market growth is driven by the rising burden of chronic diseases such as anemia, cancer, and blood disorders, which increases the need for fre... Read More »
April 2026The global real-time PCR, digital PCR, and end-point PCR market size was valued at USD 10.58 billion in 2025 and is expected to reach USD 21.31 billion by 2033, growing at a CAGR of 9.2% from 2026 to 2033. Market growth is driven by the rising prevalence of infectious diseases and cancer... Read More »
April 2026The U.S. infectious respiratory disease diagnostics market size was estimated at USD 4.50 billion in 2025 and is projected to reach USD 5.70 billion by 2033, growing at a CAGR of 2.98% from 2026 to 2033, driven by the sustained and recurring burden of viral and bacterial respiratory infe... Read More »
April 2026The U.S. drug testing market size was estimated at USD 2.62 billion in 2025, projected to reach USD 4.13 billion by 2033, expanding at a CAGR of 5.89% from 2026 to 2033. The growth of the market is driven by rising prevalence of substance abuse, stringent regulations requiring drug &... Read More »
April 2026